FDA — authorised 21 May 1975
- Status: approved
🇺🇸 Syncurine in United States
FDA authorised Syncurine on 21 May 1975
Marketing authorisations
FDA — authorised 21 May 1975
- Application: NDA006931
- Marketing authorisation holder: GLAXOSMITHKLINE
- Local brand name: SYNCURINE
- Indication: INJECTABLE — INJECTION
- Status: approved
Syncurine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in United States
Frequently asked questions
Is Syncurine approved in United States?
Yes. FDA authorised it on 21 May 1975; FDA authorised it on 21 May 1975.
Who is the marketing authorisation holder for Syncurine in United States?
Marketing authorisation holder not available in our data.